Collier David J
Insider CIK 1340886 · CDXS 10% owner · IMI Director, 10% owner · TTPH 10% owner · NEOS 10% owner · MNLO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNLO Menlo Therapeutics Inc. | S Sale | 2018-07-24 | 2018-07-26 | 487,500 | $7.65 | $3.73M | 1,907,568 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | S Sale | 2018-07-24 | 2018-07-26 | 12,500 | $7.65 | $95.6K | 48,910 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | J Other | 2018-03-02 | 2018-07-26 | 152,062 | — | $0 | 152,062 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 179 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 6,971 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 2,292,320 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 58,777 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 343,310 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 21,789 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 3,263 | — | $0 | 61,410 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 2,584 | — | $0 | 1,418,005 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 127,269 | — | $0 | 2,395,068 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 21,789 | — | $0 | 58,147 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 849,794 | — | $0 | 2,267,799 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 66 | — | $0 | 36,358 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-20 | 2016-04-20 | 8,327 | $9.88 | $82.3K | 1,559,995 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-20 | 2016-04-20 | 213 | $9.88 | $2.1K | 39,998 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-20 | 182 | $10.03 | $1.8K | 40,211 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-20 | 7,097 | $10.03 | $71.2K | 1,568,322 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-18 | 2016-04-20 | 114 | $10.10 | $1.2K | 40,393 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-18 | 2016-04-20 | 4,434 | $10.10 | $44.8K | 1,575,419 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 7,020 | $10.32 | $72.4K | 1,579,853 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 275 | $10.13 | $2.8K | 40,687 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 180 | $10.32 | $1.9K | 40,507 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-15 | 2016-04-15 | 10,735 | $10.13 | $108.7K | 1,586,873 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 325 | $10.32 | $3.4K | 40,962 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 352 | $10.27 | $3.6K | 41,287 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 12,675 | $10.32 | $130.8K | 1,597,608 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-14 | 2016-04-15 | 13,714 | $10.27 | $140.8K | 1,610,283 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-13 | 2016-04-15 | 317 | $10.16 | $3.2K | 41,639 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2016-04-13 | 2016-04-15 | 12,375 | $10.16 | $125.7K | 1,623,997 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 10,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 41,700 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 25,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 390,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 1,626,294 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 975,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 17,374 | — | $0 | 1,274,162 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 406,250 | — | $0 | 406,250 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 677,622 | — | $0 | 1,083,872 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 4,166 | — | $0 | 1,278,328 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 10,416 | — | $0 | 1,256,788 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 162,500 | — | $0 | 1,246,372 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-27 | 2015-07-28 | 10,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-27 | 2015-07-28 | 390,000 | — | $0 | 0 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2014-11-10 | 2014-11-12 | 181,067 | $2.37 | $429.1K | 0 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2014-11-10 | 2014-11-12 | 2,740,158 | $2.37 | $6.49M | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-11-10 | 2014-11-12 | 104,342 | $2.20 | $229.6K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-11-10 | 2014-11-12 | 4,376,913 | $2.20 | $9.63M | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-20 | 2014-06-25 | 1,800 | $2.86 | $5.1K | 1,000 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-19 | 2014-06-25 | 1,800 | $2.83 | $5.1K | 2,800 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-18 | 2014-06-25 | 711 | $2.75 | $2.0K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-17 | 2014-06-25 | 1,241 | $2.75 | $3.4K | 4,600 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-14 | 2014-06-25 | 1,251 | $2.75 | $3.4K | 5,841 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-14 | 2014-06-25 | 1,307 | $2.75 | $3.6K | 711 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2014-03-13 | 2014-06-25 | 1,528 | $2.72 | $4.2K | 2,018 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2014-03-12 | 2014-06-25 | 20,218 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2014-03-12 | 2014-06-25 | 22,891 | — | $0 | 104,270 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2014-03-12 | 2014-06-25 | 999,529 | — | $0 | 4,376,913 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-20 | 2,335 | $10.20 | $23.8K | 47,992 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-20 | 97,665 | $10.20 | $996.2K | 2,007,246 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-17 | 2013-09-18 | 192 | $9.48 | $1.8K | 50,327 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-17 | 2013-09-18 | 8,012 | $9.48 | $76.0K | 2,104,911 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-16 | 2013-09-18 | 1,057 | $9.22 | $9.7K | 50,519 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2013-09-16 | 2013-09-18 | 44,207 | $9.22 | $407.6K | 2,112,923 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2013-09-12 | 2014-06-25 | 3,546 | $5.61 | $19.9K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-09-09 | 2014-06-25 | 20,218 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-09-09 | 2014-06-25 | 22,891 | — | $0 | 127,161 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-09-09 | 2014-06-25 | 999,529 | — | $0 | 5,376,442 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2013-07-09 | 2014-06-25 | 400 | $7.34 | $2.9K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2013-07-05 | 2014-06-25 | 3,146 | $7.42 | $23.3K | 400 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2013-06-14 | 2014-06-25 | 3,546 | $7.28 | $25.8K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | S Sale | 2013-06-14 | 2014-06-25 | 3,546 | $7.25 | $25.7K | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-06-13 | 2014-06-25 | 20,218 | — | $0 | 0 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-06-13 | 2014-06-25 | 22,891 | — | $0 | 150,052 | SEC↗ |
| IMI INTERMOLECULAR INC | J Other | 2013-06-13 | 2014-06-25 | 999,529 | — | $0 | 6,375,971 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 64,027 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 28,485,997 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 685,531 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,153,776 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 268,269 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,662,059 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 49,088 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,040,912 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 14,786 | $7.00 | $103.5K | 51,576 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 982,275 | — | $0 | 1,529,059 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 23,639 | — | $0 | 36,790 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 384,613 | — | $0 | 546,784 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 628,071 | $7.00 | $4.40M | 2,157,130 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 91,795 | — | $0 | 162,171 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 2,208 | — | $0 | 3,901 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 70,376 | — | $0 | 70,376 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 1,693 | — | $0 | 1,693 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 9,250 | — | $0 | 13,151 | SEC↗ |